Clinical trial

HIV A6 Genome In ART Unsuccessful Patients On DOR

NCT05322083

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2022-05-01

PhaseN/A

Study timeline

Study start (estimated)2022-05-01Date precision: month

Registry last updated2022-04-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Virus-HIVunresolved

Interventions

DoravirineDRUG · verified · RxNorm: doravirine

Sponsors & collaborators

Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federationlead sponsor

MSD Pharmaceuticals LLCcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05322083 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.